EMCDDA launches COVID-19 special round of European Web Survey on Drugs to assess impact of pandemic

Loading Events

« All Events

  • This event has passed.

EMCDDA launches COVID-19 special round of European Web Survey on Drugs to assess impact of pandemic

April 24 - May 15

Crucial information on the impact of COVID-19 on people who use drugs, and on the services that support them, will be collected via a special round of the European Web Survey on Drugs, launched this week.

The survey — the Mini European Web Survey on Drugs: COVID-19 — is coordinated by the EMCDDA in collaboration with its Reitox network of national focal points.

The new survey, already available in 18 languages (1), will gather information on how patterns of drug use, access to health services and the drug market may have changed in Europe during the pandemic. This, in turn, will feed into a monthly EMCDDA trendspotter bulletin and a new repository of resources on COVID-19, launched in March on the agency’s website.

Continue reading more at: http://www.emcdda.europa.eu/news/2020/emcdda-launches-covid-19-special-round-european-web-survey-drugs-assess-impact-pandemic_en

 

__________________________________________

The Mini European Web Survey on Drugs: COVID-19 is accessible here:

https://ec.europa.eu/eusurvey/runner/Mini-EWSD-COVID-19

Menu